Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling

  1. Thomas Radimerski1,
  2. Jacques Montagne1,
  3. Maja Hemmings-Mieszczak2, and
  4. George Thomas1,3
  1. 1Friedrich Miescher Institute for Biomedical Research, CH-4058, Basel, Switzerland; 2Novartis Pharma AG, CH-4056 Basel, Switzerland

Abstract

Tuberous sclerosis complex (TSC) is a genetic disorder caused by mutations in one of two tumor suppressor genes, TSC1 andTSC2. Here, we show that absence of Drosophila Tsc1/2 leads to constitutive dS6K activation and inhibition of dPKB, the latter effect being relieved by loss of dS6K. In contrast, the dPTEN tumor suppressor, a negative effector of PI3K, has little effect on dS6K, but negatively regulates dPKB. More importantly, we demonstrate that reducing dS6K signaling rescues early larval lethality associated with loss of dTsc1/2 function, arguing that the S6K pathway is a promising target for the treatment of TSC.

Keywords

Footnotes

  • 3 Corresponding author.

  • E-MAIL gthomas{at}fmi.ch; FAX 41-61-697-3976.

  • Supplemental material is available at http://www.genesdev.org.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.239102.

    • Received June 20, 2002.
    • Accepted August 23, 2002.
| Table of Contents

Life Science Alliance